No adverse events such as elevated MTX concentration, ALT elevation, hyperbilirubinemia, or prognosis were statistically correlated to two polymorphisms in SLCO1B1 (rs11045879 and rs4149056) (Tables 2 and 3). This evidence concerns the gene GPT and Hyperbilirubinemia.